beta-thalassaemia

beta-thalassaemia

A form of THALASSAEMIA caused by failure to synthesize the beta chains of HAEMOGLOBIN.

be·ta-thal·as·se·mi·a

(bātă thală-sēmē-ă)
Thalassemia due to one of two or more genes that depress (partially or completely) synthesis of beta-globin chains by the chromosome bearing the abnormal gene.
References in periodicals archive ?
Reproductive behaviour of mothers of children with beta-thalassaemia major.
The team attempted to modify the gene responsible for beta-thalassaemia, a potentially fatal blood disorder, using a gene-editing technique known as CRISPR/Cas9.
High prevalence of the beta-thalassaemia nonsense 37 mutation in Catalonians from the Ebro delta.
Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background.
Summary: Beta-thalassaemia and sickle cell anaemia are the most prevalent genetic diseases in the emirate, according to a study by the Health Authority-Abu Dhabi (HAAD).
They found more of the healthy allele, suggesting that the foetus had inherited the correct maternal copy of the gene and would not develop beta-thalassaemia.
Posterior mediastinal masses in a patient with beta-thalassaemia intermedia.
Approximately 78% of Beta-thalassaemia Patients had Decreases in Cardiac Iron and 90% had Decreases in Liver Iron After Six Months, Interim Data Show(1)
FRIMLEY, England, December 12 /PRNewswire-FirstCall/ -- New data show once-daily Exjade(R) (deferasirox) reduces life-threatening iron levels in the heart and liver in beta-thalassaemia patients.